The main goal of these therapies is to repair or substitute the function of the faulty dystrophin gene, which plays a crucial role in DMD pathogenesis (Chung Liang et al., 2022; Moorwood et al., 2011). Here, DMD is linked to Duchenne muscular dystrophy.